Trial Profile
Docetaxel (T), Cisplatin (P) After Induction Chemotherapy With and Without Cisplatin (P) Concurrent Radiotherapy (X) Plus Bevacizumab (B) Phase II Clinical Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Aug 2018
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin; Docetaxel
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 05 Mar 2014 New trial record